Owens & Minor Inc. Aktie
Neueste Einschätzungen
Deine Einschätzung
Owens & Minor Inc. Aktie
Was spricht für und gegen Owens & Minor Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Owens & Minor Inc. im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Owens & Minor Inc. | -22,12 % | -25,42 % | -27,87 % | 44,26 % | 0,57 % | -35,15 % | - |
Orasure Tech | -0,98 % | 2,64 % | -8,18 % | -18,55 % | -32,21 % | -32,31 % | -41,83 % |
scPharmaceuticals | -3,17 % | 0,94 % | -6,55 % | -58,04 % | -25,57 % | -11,20 % | - |
SI-BONE Inc | -3,70 % | -2,99 % | -7,14 % | -39,81 % | -31,58 % | -51,13 % | - |
Kommentare
News
Owens & Minor Reports First Quarter 2024 Financial Results
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2024.
Key Highlights:
-
Consolidated revenue of $2.6 billion in the first quarter
Owens & Minor Announces First Quarter 2024 Earnings Release Date and Conference Call
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the first quarter of 2024 on Friday, May 3, 2024, before trading begins on the New York Stock Exchange.
The Company will
Owens & Minor Reports Fourth Quarter and Full Year 2023 Financial Results
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the fourth quarter and year ended December 31, 2023.
Full Year 2023 Key Highlights:
-
Consolidated revenue of $10.3 billion